Should mast cells be considered therapeutic targets in multiple sclerosis?
Karen Henriette Pinke
Sofia Fernanda Gon?alves Zorzella-Pezavento
Vanessa Soares Lara
Alexandrina Sartori
Keywords：central nervous systemdegenerative diseaseexperimental autoimmune encephalomyelitisimmunityimmunomodulatory drugsinflammatory diseaseketotifen fumaratemast cellsmultiple sclerosistherapeutic target
Publication Date：2020-11-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：13( 1995-2007 )